These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Initial results of a phase IV multicenter clinical trial of Turisteron in the treatment of prostate cancer].
    Author: Guddat HM, Schnorr D, Zemke F.
    Journal: Z Urol Nephrol; 1987 Mar; 80(3):165-70. PubMed ID: 3300098.
    Abstract:
    Turisteron proves to be a highly effective, poor in side effects, orally applicable estrogen preparation for the hormone therapy of the carcinoma of the prostate under the conditions of the routine practice. The cumulative 5-year survival rates of 197 patients observed of all categories of tumours (T1-4NxM0-1) were 66 +/- 10% and were depending upon the local growth of the tumour and upon the degree of metastasation between 81 +/- 18% and 47 +/- 42%. A discontinuation of the therapy due to strong side effects was necessary only in 4 cases (2.07%).
    [Abstract] [Full Text] [Related] [New Search]